Néostigmine Renaudin (Neostigmine Methylsulfate)

Neostigmine methylsulfate, the active ingredient in Néostigmine Renaudin, is a reversible acetylcholinesterase inhibitor presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to reverse neuromuscular blockade caused by non-depolarizing muscle relaxants in surgical patients.

GNH USA supplies Néostigmine Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Neostigmine is used primarily for its action on the cholinergic neuromuscular junction, addressing the following clinical situations: - Post‑operative postoperative reversal: Restores muscle strength after non‑depolarizing neuromuscular blocking agents. - Myasthenia gravis management : Improves symptoms by enhancing acetylcholine availability. - Reversal of curative muscle paralysis : Facilitates recovery from pharmacologically induced paralysis during diagnostic procedures such as bronchoscopy and bron  . -   a  a